Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangju Cold Granules is a traditional Chinese medicine (TCM) product manufactured by Changchun Leiyunshang Pharmaceutical. It is formulated as oral granules and is primarily indicated for the treatment of the common cold and the relief of associated symptoms such as fever, headache, nasal congestion, and cough. As a TCM preparation, it typically utilizes a combination of herbal extracts, such as *Chrysanthemum indicum* and other traditional ingredients, which work synergistically to clear heat and resolve exterior syndromes. The product is approved and commercially available in the Chinese market as part of Changchun Leiyunshang's portfolio of traditional remedies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiangju Cold Granules.